<DOC>
	<DOCNO>NCT00068926</DOCNO>
	<brief_summary>This protocol screen healthy normal volunteer participation study vaccines development NIAID 's Vaccine Research Center . Of interest vaccine : - Newly identify infectious disease SARS . - Infectious disease concern possible bioweapon , smallpox Ebola virus - Emerging infectious disease widespread geographically past , West Nile virus - For prevent disease tuberculosis malaria . Healthy normal volunteer 18 70 year age may eligible protocol . Screening begin 1 6 month start vaccine study . Participants physical examination health history , include question sexual activity drug use . Over course screen visit , participant ask give urine blood sample test various infection medical problem . Women capable get pregnant give pregnancy test . Women pregnant breastfeeding enrol study . At end screening , participant inform vaccine currently test clinical trial may eligible . Once participant enroll vaccine study , participation screen protocol end .</brief_summary>
	<brief_title>VRC 300 : Screening Healthy Volunteers Clinical Trials Investigational Vaccines Prevent Infectious Diseases</brief_title>
	<detailed_description>STUDY DESIGN : The purpose study screen potential study volunteer determine eligible infectious disease vaccine clinical trial sponsor Vaccine Research Center ( VRC ) NIH Clinical Center . All work conduct VRC Clinic National Institutes Health IRB-approved extramural site collaborate VRC Clinic . Educational material vaccine review provided subject enrollment study . SUBJECTS : Approximately 3,000 healthy adult ; age 18-70 year . STUDY DURATION : Duration participation variable , may last week several month subject . Study participation complete subject enroll vaccine study , find ineligible vaccine study decline participate vaccine study . STUDY EVALUATIONS : Evaluations usually include history , physical examination laboratory test . Only evaluation need determine eligibility particular study do . Evaluations describe protocol may do necessary eligibility study . Blood also collect storage .</detailed_description>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<criteria>INCLUSION CRITERIA : Age : 18 70 year age Available participate plan duration investigational vaccine study screen do ( vaccine study may require 6 month 18 month clinic visit ) . Able willing complete inform consent process . Agree blood store future study vaccine , immune system , and/or medical condition . EXCLUSION CRITERIA : Known infected HIV , syphilis , tuberculosis , hepatitis B hepatitis C. A condition repeat blood draw injection pose minimal risk subject hemophilia , severe coagulation disorder significantly impair venous access . A condition require active medical intervention monitoring avert serious danger participant 's health wellbeing . Known pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 29, 2011</verification_date>
	<keyword>Biodefense</keyword>
	<keyword>Prevention</keyword>
	<keyword>Emergent</keyword>
	<keyword>Virus</keyword>
	<keyword>Immune Response</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>